FDA Warns Sanofi Over Taxotere Marketing Claims
The U.S. Food and Drug Administration has warned Sanofi-Aventis over including what regulators have said are misleading statements in marketing materials for the breast cancer treatment Taxotere that tout the treatment...To view the full article, register now.
Already a subscriber? Click here to view full article